Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 3,786 | 668 | 236 | 2,728 | 887 |
| Gross Profit | 3,786 | 668 | 236 | 2,728 | 887 |
| Operating Expenses | 28,566 | 15,010 | 11,601 | 15,595 | 13,876 |
| Operating Income | -24,780 | -14,342 | -11,365 | -12,867 | -12,989 |
| Other Income | 1,941 | 118 | 106 | 242 | 2,542 |
| Pre-tax Income | -22,839 | -14,224 | -11,259 | -12,625 | -10,447 |
| Income Tax | -939 | N/A | -228 | N/A | N/A |
| Net Income Continuous | -21,900 | -14,224 | -11,031 | -12,625 | -10,447 |
| Net Income | $-21,900 | $-14,224 | $-11,031 | $-12,625 | $-10,447 |
| EPS Basic Total Ops | -0.43 | -0.36 | -0.50 | -0.73 | -0.52 |
| EPS Basic Continuous Ops | -0.43 | -0.36 | -0.50 | -0.73 | -0.51 |
| EPS Diluted Total Ops | -0.43 | -0.36 | -0.50 | -0.73 | -0.52 |
| EPS Diluted Continuous Ops | -0.43 | -0.36 | -0.50 | -0.73 | -0.51 |
| EBITDA(a) | $-6,332 | $-13,568 | $-10,489 | $-11,765 | $-12,004 |